List of Tables
Table 1. β-Nicotinamide Mononucleotide Market Trends
Table 2. β-Nicotinamide Mononucleotide Market Drivers & Opportunity
Table 3. β-Nicotinamide Mononucleotide Market Challenges
Table 4. β-Nicotinamide Mononucleotide Market Restraints
Table 5. Global β-Nicotinamide Mononucleotide Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global β-Nicotinamide Mononucleotide Revenue Market Share by Company (2019-2024)
Table 7. Global β-Nicotinamide Mononucleotide Sales Volume by Company (2019-2024) & (Tons)
Table 8. Global β-Nicotinamide Mononucleotide Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market β-Nicotinamide Mononucleotide Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers β-Nicotinamide Mononucleotide Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers β-Nicotinamide Mononucleotide Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of β-Nicotinamide Mononucleotide
Table 13. Global β-Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β-Nicotinamide Mononucleotide as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global β-Nicotinamide Mononucleotide Sales Value by Purity: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global β-Nicotinamide Mononucleotide Sales Value by Purity (2019-2024) & (US$ Million)
Table 18. Global β-Nicotinamide Mononucleotide Sales Value by Purity (2025-2030) & (US$ Million)
Table 19. Global β-Nicotinamide Mononucleotide Sales Market Share in Value by Purity (2019-2024) & (%)
Table 20. Global β-Nicotinamide Mononucleotide Sales Market Share in Value by Purity (2025-2030) & (%)
Table 21. Global β-Nicotinamide Mononucleotide Sales Volume by Purity: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global β-Nicotinamide Mononucleotide Sales Volume by Purity (2019-2024) & (Tons)
Table 23. Global β-Nicotinamide Mononucleotide Sales Volume by Purity (2025-2030) & (Tons)
Table 24. Global β-Nicotinamide Mononucleotide Sales Market Share in Volume by Purity (2019-2024) & (%)
Table 25. Global β-Nicotinamide Mononucleotide Sales Market Share in Volume by Purity (2025-2030) & (%)
Table 26. Global β-Nicotinamide Mononucleotide Price by Purity (2019-2024) & (US$/Ton)
Table 27. Global β-Nicotinamide Mononucleotide Price by Purity (2025-2030) & (US$/Ton)
Table 28. Global β-Nicotinamide Mononucleotide Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global β-Nicotinamide Mononucleotide Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global β-Nicotinamide Mononucleotide Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global β-Nicotinamide Mononucleotide Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global β-Nicotinamide Mononucleotide Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global β-Nicotinamide Mononucleotide Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
Table 34. Global β-Nicotinamide Mononucleotide Sales Volume by Application (2019-2024) & (Tons)
Table 35. Global β-Nicotinamide Mononucleotide Sales Volume by Application (2025-2030) & (Tons)
Table 36. Global β-Nicotinamide Mononucleotide Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global β-Nicotinamide Mononucleotide Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global β-Nicotinamide Mononucleotide Price by Application (2019-2024) & (US$/Ton)
Table 39. Global β-Nicotinamide Mononucleotide Price by Application (2025-2030) & (US$/Ton)
Table 40. Global β-Nicotinamide Mononucleotide Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global β-Nicotinamide Mononucleotide Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global β-Nicotinamide Mononucleotide Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global β-Nicotinamide Mononucleotide Sales Value by Region (2019-2024) & (%)
Table 44. Global β-Nicotinamide Mononucleotide Sales Value by Region (2025-2030) & (%)
Table 45. Global β-Nicotinamide Mononucleotide Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
Table 46. Global β-Nicotinamide Mononucleotide Sales Volume by Region (2019-2024) & (Tons)
Table 47. Global β-Nicotinamide Mononucleotide Sales Volume by Region (2025-2030) & (Tons)
Table 48. Global β-Nicotinamide Mononucleotide Sales Volume by Region (2019-2024) & (%)
Table 49. Global β-Nicotinamide Mononucleotide Sales Volume by Region (2025-2030) & (%)
Table 50. Global β-Nicotinamide Mononucleotide Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global β-Nicotinamide Mononucleotide Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions β-Nicotinamide Mononucleotide Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions β-Nicotinamide Mononucleotide Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions β-Nicotinamide Mononucleotide Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions β-Nicotinamide Mononucleotide Sales Volume, (2019-2024) & (Tons)
Table 56. Key Countries/Regions β-Nicotinamide Mononucleotide Sales Volume, (2025-2030) & (Tons)
Table 57. GeneHarbor Company Information
Table 58. GeneHarbor Introduction and Business Overview
Table 59. GeneHarbor β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. GeneHarbor β-Nicotinamide Mononucleotide Product Offerings
Table 61. GeneHarbor Recent Development
Table 62. Quicksilver Scientific Company Information
Table 63. Quicksilver Scientific Introduction and Business Overview
Table 64. Quicksilver Scientific β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. Quicksilver Scientific β-Nicotinamide Mononucleotide Product Offerings
Table 66. Quicksilver Scientific Recent Development
Table 67. Age Science Company Information
Table 68. Age Science Introduction and Business Overview
Table 69. Age Science β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. Age Science β-Nicotinamide Mononucleotide Product Offerings
Table 71. Age Science Recent Development
Table 72. Herbalmax Company Information
Table 73. Herbalmax Introduction and Business Overview
Table 74. Herbalmax β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. Herbalmax β-Nicotinamide Mononucleotide Product Offerings
Table 76. Herbalmax Recent Development
Table 77. Genex Formulas Company Information
Table 78. Genex Formulas Introduction and Business Overview
Table 79. Genex Formulas β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. Genex Formulas β-Nicotinamide Mononucleotide Product Offerings
Table 81. Genex Formulas Recent Development
Table 82. Nutravita Company Information
Table 83. Nutravita Introduction and Business Overview
Table 84. Nutravita β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Nutravita β-Nicotinamide Mononucleotide Product Offerings
Table 86. Nutravita Recent Development
Table 87. Shinkowa Pharmaceutical Company Information
Table 88. Shinkowa Pharmaceutical Introduction and Business Overview
Table 89. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Product Offerings
Table 91. Shinkowa Pharmaceutical Recent Development
Table 92. Oriental Yeast Company Information
Table 93. Oriental Yeast Introduction and Business Overview
Table 94. Oriental Yeast β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Oriental Yeast β-Nicotinamide Mononucleotide Product Offerings
Table 96. Oriental Yeast Recent Development
Table 97. Maac10 Formulas Company Information
Table 98. Maac10 Formulas Introduction and Business Overview
Table 99. Maac10 Formulas β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Maac10 Formulas β-Nicotinamide Mononucleotide Product Offerings
Table 101. Maac10 Formulas Recent Development
Table 102. EffePharm Company Information
Table 103. EffePharm Introduction and Business Overview
Table 104. EffePharm β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. EffePharm β-Nicotinamide Mononucleotide Product Offerings
Table 106. EffePharm Recent Development
Table 107. Nutriop Company Information
Table 108. Nutriop Introduction and Business Overview
Table 109. Nutriop β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 110. Nutriop β-Nicotinamide Mononucleotide Product Offerings
Table 111. Nutriop Recent Development
Table 112. Bontac Company Information
Table 113. Bontac Introduction and Business Overview
Table 114. Bontac β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. Bontac β-Nicotinamide Mononucleotide Product Offerings
Table 116. Bontac Recent Development
Table 117. CELFULL Company Information
Table 118. CELFULL Introduction and Business Overview
Table 119. CELFULL β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 120. CELFULL β-Nicotinamide Mononucleotide Product Offerings
Table 121. CELFULL Recent Development
Table 122. ChromaDex Company Information
Table 123. ChromaDex Introduction and Business Overview
Table 124. ChromaDex β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 125. ChromaDex β-Nicotinamide Mononucleotide Product Offerings
Table 126. ChromaDex Recent Development
Table 127. Kingdomway Company Information
Table 128. Kingdomway Introduction and Business Overview
Table 129. Kingdomway β-Nicotinamide Mononucleotide Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 130. Kingdomway β-Nicotinamide Mononucleotide Product Offerings
Table 131. Kingdomway Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. β-Nicotinamide Mononucleotide Downstream Customers
Table 135. β-Nicotinamide Mononucleotide Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. β-Nicotinamide Mononucleotide Product Picture
Figure 2. Global β-Nicotinamide Mononucleotide Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global β-Nicotinamide Mononucleotide Sales Value (2019-2030) & (US$ Million)
Figure 4. Global β-Nicotinamide Mononucleotide Sales Volume (2019-2030) & (Tons)
Figure 5. Global β-Nicotinamide Mononucleotide Sales Price (2019-2030) & (US$/Ton)
Figure 6. β-Nicotinamide Mononucleotide Report Years Considered
Figure 7. Global β-Nicotinamide Mononucleotide Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global β-Nicotinamide Mononucleotide Players Sales Volume Ranking (2023) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by β-Nicotinamide Mononucleotide Revenue in 2023
Figure 10. β-Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Above 98% Picture
Figure 12. ＜98% Picture
Figure 13. Global β-Nicotinamide Mononucleotide Sales Value by Purity (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global β-Nicotinamide Mononucleotide Sales Value Market Share by Purity, 2023 & 2030
Figure 15. Global β-Nicotinamide Mononucleotide Sales Volume by Purity (2019 VS 2023 VS 2030) & (Tons)
Figure 16. Global β-Nicotinamide Mononucleotide Sales Volume Market Share by Purity, 2023 & 2030
Figure 17. Global β-Nicotinamide Mononucleotide Price by Purity (2019-2030) & (US$/Ton)
Figure 18. Product Picture of Drug
Figure 19. Product Picture of Health Products
Figure 20. Product Picture of Cosmetic
Figure 21. Product Picture of Others
Figure 22. Global β-Nicotinamide Mononucleotide Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global β-Nicotinamide Mononucleotide Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global β-Nicotinamide Mononucleotide Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 25. Global β-Nicotinamide Mononucleotide Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global β-Nicotinamide Mononucleotide Price by Application (2019-2030) & (US$/Ton)
Figure 27. North America β-Nicotinamide Mononucleotide Sales Value (2019-2030) & (US$ Million)
Figure 28. North America β-Nicotinamide Mononucleotide Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe β-Nicotinamide Mononucleotide Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe β-Nicotinamide Mononucleotide Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific β-Nicotinamide Mononucleotide Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific β-Nicotinamide Mononucleotide Sales Value by Country (%), 2023 VS 2030
Figure 33. South America β-Nicotinamide Mononucleotide Sales Value (2019-2030) & (US$ Million)
Figure 34. South America β-Nicotinamide Mononucleotide Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa β-Nicotinamide Mononucleotide Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa β-Nicotinamide Mononucleotide Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions β-Nicotinamide Mononucleotide Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions β-Nicotinamide Mononucleotide Sales Volume (%), (2019-2030)
Figure 39. United States β-Nicotinamide Mononucleotide Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States β-Nicotinamide Mononucleotide Sales Value by Purity (%), 2023 VS 2030
Figure 41. United States β-Nicotinamide Mononucleotide Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe β-Nicotinamide Mononucleotide Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe β-Nicotinamide Mononucleotide Sales Value by Purity (%), 2023 VS 2030
Figure 44. Europe β-Nicotinamide Mononucleotide Sales Value by Application (%), 2023 VS 2030
Figure 45. China β-Nicotinamide Mononucleotide Sales Value, (2019-2030) & (US$ Million)
Figure 46. China β-Nicotinamide Mononucleotide Sales Value by Purity (%), 2023 VS 2030
Figure 47. China β-Nicotinamide Mononucleotide Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan β-Nicotinamide Mononucleotide Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan β-Nicotinamide Mononucleotide Sales Value by Purity (%), 2023 VS 2030
Figure 50. Japan β-Nicotinamide Mononucleotide Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea β-Nicotinamide Mononucleotide Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea β-Nicotinamide Mononucleotide Sales Value by Purity (%), 2023 VS 2030
Figure 53. South Korea β-Nicotinamide Mononucleotide Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia β-Nicotinamide Mononucleotide Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia β-Nicotinamide Mononucleotide Sales Value by Purity (%), 2023 VS 2030
Figure 56. Southeast Asia β-Nicotinamide Mononucleotide Sales Value by Application (%), 2023 VS 2030
Figure 57. India β-Nicotinamide Mononucleotide Sales Value, (2019-2030) & (US$ Million)
Figure 58. India β-Nicotinamide Mononucleotide Sales Value by Purity (%), 2023 VS 2030
Figure 59. India β-Nicotinamide Mononucleotide Sales Value by Application (%), 2023 VS 2030
Figure 60. β-Nicotinamide Mononucleotide Industrial Chain
Figure 61. β-Nicotinamide Mononucleotide Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
